New Zealand markets closed

Aurobindo Pharma Limited (AUROPHARMA.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
1,207.60+19.35 (+1.63%)
At close: 03:29PM IST
Full screen
Previous close1,188.25
Open1,195.20
Bid0.00 x 0
Ask0.00 x 0
Day's range1,192.00 - 1,214.70
52-week range708.85 - 1,292.10
Volume1,204,035
Avg. volume1,637,054
Market cap706.651B
Beta (5Y monthly)0.51
PE ratio (TTM)22.32
EPS (TTM)54.10
Earnings date10 Aug 2024 - 14 Aug 2024
Forward dividend & yield4.50 (0.37%)
Ex-dividend date20 Feb 2024
1y target est953.00
  • Investing.com

    Aurobindo Pharma Outperforms Expectations with Strong Q4, Eyes Robust Growth Ahead

    Aurobindo Pharma (NS:ARBN) has outperformed expectations in the fourth quarter of FY24, with both sales and EBITDA showing significant year-over-year growth. Sales increased by 17%, while EBITDA surged by an impressive 68%, surpassing both Goldman Sachs (NYSE:GS)' projections and those of the broader market. The EBITDA margin also exceeded forecasts, reaching 22.3%, which is 101 basis points higher than Goldman Sachs' estimate.